About
Services
Capabilities
Resources
More
Achieving Clinically Relevant Yields of High-Potency CAR-NK Cell Expansion
Building Better mRNA Therapeutics
Polarization State Specific Synthetic Promoters for Control of Macrophage Cell Therapies
Iterative Engineering of Polarization-State Responsive Synthetic Promoters for Autonomous Control of Macrophage Polarization Logic
A Platform for Designing Neuron, Astrocyte and Hepatocyte Specific Promoters for Gene Therapy
Engineered Small Molecule Binding Domains for Pharmacologically Responsive Degradation and Proximity Based Therapeutics
Engineered IMiD Regulated Synthetic Transcriptional Switch for Controlled and Dose-Responsive Expression of Therapeutic Payload within FDA-Approved Drug Doses
Small-molecule Regulated Safety Switch for Improved Safety of CAR Cell Therapies in the Brain
Genome-Orthogonal Gene Circuitry: Improved Synthetic Enhancer-Transcription Factor Systems with Minimal Off-Target Effects
Smart Sensor Promoters Drive State-specific Gene Circuits to Convert Immunosuppressive Macrophages into an Anti-tumor Phenotype
Dynamic Injury Response through Engineered Cellular Targeting (DIRECT) - In collaboration with DARPA